1796 related articles for article (PubMed ID: 11886323)
1. Hypertrophic cardiomyopathy: a systematic review.
Maron BJ
JAMA; 2002 Mar; 287(10):1308-20. PubMed ID: 11886323
[TBL] [Abstract][Full Text] [Related]
2. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.
Maron BJ; Ommen SR; Semsarian C; Spirito P; Olivotto I; Maron MS
J Am Coll Cardiol; 2014 Jul; 64(1):83-99. PubMed ID: 24998133
[TBL] [Abstract][Full Text] [Related]
3. Hypertrophic cardiomyopathy.
Maron BJ; Maron MS
Lancet; 2013 Jan; 381(9862):242-55. PubMed ID: 22874472
[TBL] [Abstract][Full Text] [Related]
4. [Hypertrophic cardiomyopathy: current aspects and new developments].
Desnos M
Bull Acad Natl Med; 2012; 196(4-5):997-1009; discussion 1009-10. PubMed ID: 23550458
[TBL] [Abstract][Full Text] [Related]
5. [Interventional treatment in hypertrophic cardiomyopathy].
Gietzen FH; Schümmelfeder J; Neuser H; Brunn J; Schumacher B; Kerber S
Herz; 2005 Mar; 30(2):102-10. PubMed ID: 15875098
[TBL] [Abstract][Full Text] [Related]
6. Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.
Marian AJ; Braunwald E
Circ Res; 2017 Sep; 121(7):749-770. PubMed ID: 28912181
[TBL] [Abstract][Full Text] [Related]
7. Management of hypertrophic cardiomyopathy in children.
Seggewiss H; Rigopoulos A
Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ
Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796
[TBL] [Abstract][Full Text] [Related]
9. Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review.
Kuusisto J; Sipola P; Jääskeläinen P; Naukkarinen A
Ann Med; 2016 Nov; 48(7):496-508. PubMed ID: 27460395
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
Maron BJ; Rowin EJ; Casey SA; Lesser JR; Garberich RF; McGriff DM; Maron MS
Circulation; 2016 Jan; 133(1):62-73. PubMed ID: 26518766
[TBL] [Abstract][Full Text] [Related]
11. Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).
Ho CY; Day SM; Ashley EA; Michels M; Pereira AC; Jacoby D; Cirino AL; Fox JC; Lakdawala NK; Ware JS; Caleshu CA; Helms AS; Colan SD; Girolami F; Cecchi F; Seidman CE; Sajeev G; Signorovitch J; Green EM; Olivotto I
Circulation; 2018 Oct; 138(14):1387-1398. PubMed ID: 30297972
[TBL] [Abstract][Full Text] [Related]
12. Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
Maron BJ; Rowin EJ; Casey SA; Link MS; Lesser JR; Chan RH; Garberich RF; Udelson JE; Maron MS
J Am Coll Cardiol; 2015 May; 65(18):1915-28. PubMed ID: 25953744
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
[TBL] [Abstract][Full Text] [Related]
14. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.
Maron BJ; Casey SA; Poliac LC; Gohman TE; Almquist AK; Aeppli DM
JAMA; 1999 Feb; 281(7):650-5. PubMed ID: 10029128
[TBL] [Abstract][Full Text] [Related]
15. Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality in 2023.
Maron BJ; Rowin EJ; Maron MS
Am J Cardiol; 2024 Feb; 212S():S77-S82. PubMed ID: 38368039
[TBL] [Abstract][Full Text] [Related]
16. Management of hypertrophic cardiomyopathy.
Enriquez AD; Goldman ME
Ann Glob Health; 2014; 80(1):35-45. PubMed ID: 24751563
[TBL] [Abstract][Full Text] [Related]
17. Low Risk of Hypertrophic Cardiomyopathy With Contemporary Management Strategies Implemented in Non-Referral Regional Community-Based Practices.
Shirani J; Aurshiya R; Elshaikh A; Olenchock SA; Rowin EJ; Maron MS; Maron BJ
Am J Cardiol; 2021 Mar; 142():130-135. PubMed ID: 33279482
[TBL] [Abstract][Full Text] [Related]
18. Hypertrophic cardiomyopathy: a review of etiology and treatment.
Jurynec J
J Cardiovasc Nurs; 2007; 22(1):65-73; quiz 74-5. PubMed ID: 17224700
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of present and future pharmaco-structural therapies for hypertrophic cardiomyopathy.
Sawan MA; Prabakaran S; D'Souza M; Behbahani-Nejad O; Gold ME; Williams BR; Bilen O
Clin Cardiol; 2024 Jan; 47(1):e24207. PubMed ID: 38269637
[TBL] [Abstract][Full Text] [Related]
20. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
